Leaflet NEOTON 1g powder infusion solution


Indicated for: cardiac metabolic support

Route of administration: infusion

Substance: phosphocreatinin (cardioprotective metabolic agent)

ATC: C01EB06 (Cardiovascular system | Other cardiac preparations)

Phosphocreatinine (or creatine phosphate) is a molecule involved in the energy metabolism of cells, particularly muscle and nerve cells. It serves as a storage form of chemical energy in cells and is used to rapidly regenerate adenosine triphosphate (ATP), the body's primary energy source, during intense physical activity or other energy-demanding processes.

Phosphocreatinine is synthesized in the liver, kidneys, and pancreas and is primarily stored in skeletal muscles. During physical exertion, phosphocreatinine donates a phosphate group to convert adenosine diphosphate (ADP) into ATP, providing a quick source of energy.

In medicine, phosphocreatinine levels can be indirectly assessed by measuring serum creatinine, a breakdown product of phosphocreatinine, to evaluate kidney function.

General data about NEOTON 1g

  • Substance: phosphocreatinin
  • Date of last drug list: 01-05-2026
  • Commercial code: W70320002
  • Concentration: 1g
  • Pharmaceutical form: powder infusion solution
  • Quantity: 1
  • Product type: original
  • Price: 91.98 RON
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: ALFASIGMA S.P.A. - ITALIA
  • Holder: ADDENDA PHARMACEUTICALS S.R.L. - ROMANIA
  • Number: 6986/2014/01
  • Shelf life: 3 years

Pharmaceutical forms available for phosphocreatinin